Investigating how glial cells affect brain health in Parkinson's disease
Glial Involvement in REDOX Homeostasis in the Substantia Nigra
This study is looking at how certain brain cells called glial cells might play a role in Parkinson's disease, focusing on how inflammation and genetic changes affect them, with the hope of finding new ways to help people with the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11084559 on NIH RePORTER |
What this research studies
This research explores the role of glial cells, specifically astrocytes and microglia, in the development of Parkinson's disease (PD). It aims to understand how inflammation and genetic mutations influence the function of these cells and their contribution to neuronal loss in PD. By using bioinformatics to identify genes linked to PD that are active in glial cells, the study seeks to uncover mechanisms that may lead to new therapeutic targets. Patients may benefit from insights into how glial dysfunction contributes to their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease, particularly those with a family history of the condition.
Not a fit: Patients with Parkinson's disease who do not have any genetic predisposition or those with other neurological disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that target glial cell function to slow or prevent the progression of Parkinson's disease.
How similar studies have performed: Other research has shown promising results in understanding the role of glial cells in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Cowell, Rita Marie — University of Alabama at Birmingham
- Study coordinator: Cowell, Rita Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.